Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs and serve the local markets.
Highlights
The global Outsourcing in Drug Discovery market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Outsourcing in Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Outsourcing in Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Outsourcing in Drug Discovery in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Outsourcing in Drug Discovery include Charles River Laboratories, ICON, Parexel, PPD, PRA Health Sciences, Wuxi AppTec and Recipharm, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Outsourcing in Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Outsourcing in Drug Discovery.
The Outsourcing in Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Outsourcing in Drug Discovery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Outsourcing in Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Charles River Laboratories
ICON
Parexel
PPD
PRA Health Sciences
Wuxi AppTec
Recipharm
Segment by Type
Small Molecules
Large Molecules
Segment by Application
Hospitals and Clinics
Medical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Outsourcing in Drug Discovery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Outsourcing in Drug Discovery 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Small Molecules
1.2.3 Large Molecules
1.3 麻豆原创 by Application
1.3.1 Global Outsourcing in Drug Discovery 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Medical Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Outsourcing in Drug Discovery 麻豆原创 Perspective (2018-2029)
2.2 Outsourcing in Drug Discovery Growth Trends by Region
2.2.1 Global Outsourcing in Drug Discovery 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Outsourcing in Drug Discovery Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Outsourcing in Drug Discovery Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Outsourcing in Drug Discovery 麻豆原创 Dynamics
2.3.1 Outsourcing in Drug Discovery Industry Trends
2.3.2 Outsourcing in Drug Discovery 麻豆原创 Drivers
2.3.3 Outsourcing in Drug Discovery 麻豆原创 Challenges
2.3.4 Outsourcing in Drug Discovery 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Outsourcing in Drug Discovery Players by Revenue
3.1.1 Global Top Outsourcing in Drug Discovery Players by Revenue (2018-2023)
3.1.2 Global Outsourcing in Drug Discovery Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Outsourcing in Drug Discovery 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Outsourcing in Drug Discovery Revenue
3.4 Global Outsourcing in Drug Discovery 麻豆原创 Concentration Ratio
3.4.1 Global Outsourcing in Drug Discovery 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Outsourcing in Drug Discovery Revenue in 2022
3.5 Outsourcing in Drug Discovery Key Players Head office and Area Served
3.6 Key Players Outsourcing in Drug Discovery Product Solution and Service
3.7 Date of Enter into Outsourcing in Drug Discovery 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Outsourcing in Drug Discovery Breakdown Data by Type
4.1 Global Outsourcing in Drug Discovery Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Outsourcing in Drug Discovery Forecasted 麻豆原创 Size by Type (2024-2029)
5 Outsourcing in Drug Discovery Breakdown Data by Application
5.1 Global Outsourcing in Drug Discovery Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Outsourcing in Drug Discovery Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Outsourcing in Drug Discovery 麻豆原创 Size (2018-2029)
6.2 North America Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2018-2023)
6.4 North America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Outsourcing in Drug Discovery 麻豆原创 Size (2018-2029)
7.2 Europe Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Outsourcing in Drug Discovery 麻豆原创 Size by Country (2018-2023)
7.4 Europe Outsourcing in Drug Discovery 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Outsourcing in Drug Discovery 麻豆原创 Size (2018-2029)
9.2 Latin America Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Outsourcing in Drug Discovery Introduction
11.1.4 Charles River Laboratories Revenue in Outsourcing in Drug Discovery Business (2018-2023)
11.1.5 Charles River Laboratories Recent Development
11.2 ICON
11.2.1 ICON Company Detail
11.2.2 ICON Business Overview
11.2.3 ICON Outsourcing in Drug Discovery Introduction
11.2.4 ICON Revenue in Outsourcing in Drug Discovery Business (2018-2023)
11.2.5 ICON Recent Development
11.3 Parexel
11.3.1 Parexel Company Detail
11.3.2 Parexel Business Overview
11.3.3 Parexel Outsourcing in Drug Discovery Introduction
11.3.4 Parexel Revenue in Outsourcing in Drug Discovery Business (2018-2023)
11.3.5 Parexel Recent Development
11.4 PPD
11.4.1 PPD Company Detail
11.4.2 PPD Business Overview
11.4.3 PPD Outsourcing in Drug Discovery Introduction
11.4.4 PPD Revenue in Outsourcing in Drug Discovery Business (2018-2023)
11.4.5 PPD Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Detail
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences Outsourcing in Drug Discovery Introduction
11.5.4 PRA Health Sciences Revenue in Outsourcing in Drug Discovery Business (2018-2023)
11.5.5 PRA Health Sciences Recent Development
11.6 Wuxi AppTec
11.6.1 Wuxi AppTec Company Detail
11.6.2 Wuxi AppTec Business Overview
11.6.3 Wuxi AppTec Outsourcing in Drug Discovery Introduction
11.6.4 Wuxi AppTec Revenue in Outsourcing in Drug Discovery Business (2018-2023)
11.6.5 Wuxi AppTec Recent Development
11.7 Recipharm
11.7.1 Recipharm Company Detail
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Outsourcing in Drug Discovery Introduction
11.7.4 Recipharm Revenue in Outsourcing in Drug Discovery Business (2018-2023)
11.7.5 Recipharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Charles River Laboratories
ICON
Parexel
PPD
PRA Health Sciences
Wuxi AppTec
Recipharm
听
听
*If Applicable.
